Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » The Scan » RNAi Drug for Acute Hepatic Porphyria

RNAi Drug for Acute Hepatic Porphyria

Nov 21, 2019

The US Food and Drug Administration has approved the RNA interference drug givosiran (Alnylam Pharmaceuticals' Givlaari) to treat acute hepatic porphyria in adults, according to the agency.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Robots for the Lab

Researchers have developed a robotic lab assistant, the Verge reports.

Ruling Awaited

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

To Find Where It Came From

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

Science Presents Atlas of Aberrant Cells in Lung Condition, More

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  2. FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

  3. FDA Grants EUAs for Enzo Life Sciences, Access Bio, Gene By Gene Coronavirus Tests

  4. Laboratorio Clinico Toledo, Assure Tech Coronavirus Tests Get Emergency Use Authorizations

  5. DiaSorin Molecular Gets CE Mark for Flu, RSV Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.